15q12

15q12 refers to a cytogenetic region on the long arm of chromosome 15. The band 15q12 is a hotspot for copy number variation, and both microdeletions and microduplications in this area have been observed in clinical genetic testing. While many people with variations in this region are unaffected, changes in 15q12 have been associated with neurodevelopmental differences in some individuals.

Genetic variants in 15q12 are typically copy-number changes that can be inherited or occur de novo. The resulting phenotypes are highly variable: some individuals with a deletion or duplication in 15q12 have developmental delays or learning difficulties, while others show subtler or no apparent problems. This variability reflects incomplete penetrance and variable expressivity, and the specific contribution of individual genes in 15q12 to any given presentation remains an active area of research.

Clinical features reported in association with 15q12 CNVs include developmental delay, intellectual disability, autism spectrum disorders, speech and language impairments, and epilepsy or seizures. Additional behavioral and cognitive issues, such as attention difficulties or coordination problems, may be present. Because the presentation can vary widely, accurate diagnosis often relies on genome-wide testing rather than targeted testing of a single region.

Diagnosis typically involves chromosome microarray analysis (CMA) or array comparative genomic hybridization to detect submicroscopic deletions or duplications in 15q12. In some cases, fluorescence in situ hybridization (FISH) or standard karyotyping may be used. If a 15q12 CNV is found, testing of the parents helps determine whether the variant is de novo or inherited, which informs recurrence risk and genetic counseling.

Management is individualized and usually multidisciplinary, focusing on the specific needs of the person with the CNV. Interventions may include early intervention services, speech and language therapy, occupational therapy, educational support, and treatment for seizures or behavioral issues when present. Because the clinical effects are variable, prognosis depends on the size of the genetic change, associated conditions, and the effectiveness of available therapies, with ongoing research aimed at clarifying which genes in 15q12 contribute to disease risk.